Pseudohypoparathyroidism screening: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
Mazia Fatima (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pseudohypoparathyroidism}} | {{Pseudohypoparathyroidism}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{Mazia}} | ||
==Overview== | |||
There is insufficient evidence to recommend routine screening for pseudohypoparathyroidism. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for pseudohypoparathyroidism. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] |
Revision as of 19:28, 28 September 2017
Pseudohypoparathyroidism Microchapters |
Differentiating Pseudohypoparathyroidism from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Pseudohypoparathyroidism screening On the Web |
American Roentgen Ray Society Images of Pseudohypoparathyroidism screening |
Risk calculators and risk factors for Pseudohypoparathyroidism screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Overview
There is insufficient evidence to recommend routine screening for pseudohypoparathyroidism.
Screening
There is insufficient evidence to recommend routine screening for pseudohypoparathyroidism.